UBS analyst Matthew Taylor maintained a Buy rating on Medtronic (MDT) today and set a price target of $122. The company’s shares closed last Monday at $106.91, close to its 52-week high of $109.70.
According to TipRanks.com, Taylor is a 5-star analyst with an average return of 11.2% and a 71.2% success rate. Taylor covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Edwards Lifesciences, and Intuitive Surgical.
Currently, the analyst consensus on Medtronic is a Strong Buy with an average price target of $114.20, which is a 6.8% upside from current levels. In a report issued on August 14, Cowen & Co. also maintained a Buy rating on the stock with a $111 price target.
See today’s analyst top recommended stocks >>
Medtronic’s market cap is currently $143.4B and has a P/E ratio of 31.26. The company has a Price to Book ratio of 2.86.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
